University of Oulu

The ESHRE COVID-19 Working Group, Luca Gianaroli, Baris Ata, Kersti Lundin, Satu Rautakallio-Hokkanen, Juha S Tapanainen, Nathalie Vermeulen, Anna Veiga, Edgar Mocanu, The calm after the storm: re-starting ART treatments safely in the wake of the COVID-19 pandemic, Human Reproduction, Volume 36, Issue 2, February 2021, Pages 275–282,

The calm after the storm : re-starting ART treatments safely in the wake of the COVID-19 pandemic

Saved in:
Author: The ESHRE COVID-19 Working Group; Gianaroli, Luca1; Ata, Baris2;
Organizations: 1Societa` Italiana Studi di Medicina della Riproduzione, S.I.S.Me.R. Reproductive Medicine Institute, Bologna, Emilia-Romagna, Italy
2Obstetrics and Gynecology Department, Koc University, Istanbul, Turkey
3Reproductive Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden
4Fertility Europe Evere, Evere, Belgium
5Department of Obstetrics and Gynaecology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland
6Department of Obstetrics and Gynaecology, University of Oulu, Oulu University Hospital and Medical Research Centre, PEDEGO Research Unit, Oulu, Finland
7ESHRE Central Office, Grimbergen, Belgium
8Reproductive Medicine Service, Dexeus Mujer, Hospital Universitari Dexeus/Institut d’Investigacio ́ Biome`dica de Bellvitge, IDIBELL, Barcelona Stem Cell Bank, Regenerative Medicine Programme, Barcelona, Spain
9Rotunda Hospital and Royal College of Surgeons in Ireland, Dublin, Ireland
Format: article
Version: published version
Access: open
Online Access: PDF Full Text (PDF, 0.4 MB)
Persistent link:
Language: English
Published: Oxford University Press, 2021
Publish Date: 2021-07-08


The coronavirus disease 2019 (COVID-19) pandemic created a significant impact on medically assisted reproduction (MAR) services. ESHRE decided to mobilize resources in order to collect, analyse, monitor, prepare and disseminate severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) knowledge specifically related to ART and early pregnancy. This article presents the impact of the SARS-CoV-2 pandemic focusing on reproductive healthcare. It details the rationale behind the guidance prepared to support MAR services in organizing and managing the re-start of treatments or in case of any future wave of COVID-19 disease. The guidance includes information on patient selection and informed consent, staff and patient triage and testing, adaptation of ART services, treatment planning and code of conduct. The initiatives detailed in this article are not necessarily COVID-specific and such action plans could be applied effectively to manage similar emergency situations in different areas of medicine, in the future.

see all

Series: Human reproduction
ISSN: 0268-1161
ISSN-E: 1460-2350
ISSN-L: 0268-1161
Volume: 36
Issue: 2
Pages: 275 - 282
DOI: 10.1093/humrep/deaa285
Type of Publication: A1 Journal article – refereed
Field of Science: 3121 General medicine, internal medicine and other clinical medicine
Copyright information: © The Author(s) 2020. Published by Oxford University Press on behalf of European Society of Human Reproduction and Embryology. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (, which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact